These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 1474984)
1. Candida albicans antifungal-resistant strains: studies on adherence and other pathogenicity related characteristics. Ghannoum MA Mycoses; 1992; 35(5-6):131-9. PubMed ID: 1474984 [TBL] [Abstract][Full Text] [Related]
2. Influence of antifungal polyenes on the adhesion of Candida albicans and Candida glabrata to human epithelial cells in vitro. Dorocka-Bobkowska B; Konopka K; Düzgüneş N Arch Oral Biol; 2003 Dec; 48(12):805-14. PubMed ID: 14596870 [TBL] [Abstract][Full Text] [Related]
3. Correlative relationship between proteinase production, adherence and pathogenicity of various strains of Candida albicans. Ghannoum M; Abu Elteen K J Med Vet Mycol; 1986 Oct; 24(5):407-13. PubMed ID: 3537262 [TBL] [Abstract][Full Text] [Related]
4. Effects of the binding of a Helianthus annuus lectin to Candida albicans cell wall on biofilm development and adhesion to host cells. Del Rio M; de la Canal L; Pinedo M; Mora-Montes HM; Regente M Phytomedicine; 2019 May; 58():152875. PubMed ID: 30884454 [TBL] [Abstract][Full Text] [Related]
5. Increase of virulence and its phenotypic traits in drug-resistant strains of Candida albicans. Angiolella L; Stringaro AR; De Bernardis F; Posteraro B; Bonito M; Toccacieli L; Torosantucci A; Colone M; Sanguinetti M; Cassone A; Palamara AT Antimicrob Agents Chemother; 2008 Mar; 52(3):927-36. PubMed ID: 18180350 [TBL] [Abstract][Full Text] [Related]
6. [Characteristics of a strain of C. albicans resistant to polyene antibiotics]. Mikhaĭlova MA; Virina AM; Kravchenko TI Antibiotiki; 1979 Nov; 24(11):828-31. PubMed ID: 389154 [TBL] [Abstract][Full Text] [Related]
7. Synergic effects of tactolimus and azole antifungal agents against azole-resistant Candida albican strains. Maesaki S; Marichal P; Hossain MA; Sanglard D; Vanden Bossche H; Kohno S J Antimicrob Chemother; 1998 Dec; 42(6):747-53. PubMed ID: 10052898 [TBL] [Abstract][Full Text] [Related]
8. Virulence factors and antifungal susceptibility of Candida albicans isolates from oral candidosis patients and control individuals. Koga-Ito CY; Lyon JP; Vidotto V; de Resende MA Mycopathologia; 2006 Apr; 161(4):219-23. PubMed ID: 16552484 [TBL] [Abstract][Full Text] [Related]
9. Amphotericin B resistance leads to enhanced proteinase and phospholipase activity and reduced germ tube formation in Candida albicans. Kumar R; Shukla PK Fungal Biol; 2010; 114(2-3):189-97. PubMed ID: 20943129 [TBL] [Abstract][Full Text] [Related]
10. Comparative pathogenicity of auxotrophic mutants of Candida albicans. Manning M; Snoddy CB; Fromtling RA Can J Microbiol; 1984 Jan; 30(1):31-5. PubMed ID: 6370397 [TBL] [Abstract][Full Text] [Related]
11. The correlation of virulence, pathogenicity, and itraconazole resistance with SAP activity in Candida albicans strains. Feng W; Yang J; Pan Y; Xi Z; Qiao Z; Ma Y Can J Microbiol; 2016 Feb; 62(2):173-8. PubMed ID: 26751517 [TBL] [Abstract][Full Text] [Related]
12. Aculeacin A resistant mutants of Candida albicans. Mehta RJ; Nash CH; Grappel SF; Actor P J Antibiot (Tokyo); 1982 Jun; 35(6):707-11. PubMed ID: 6749782 [TBL] [Abstract][Full Text] [Related]
13. Sterols in Candida albicans mutants resistant to polyene or azole antifungals, and of a double mutant C. albicans 6.4. Hitchcock CA; Russell NJ; Barrett-Bee KJ Crit Rev Microbiol; 1987; 15(1):111-5. PubMed ID: 3319418 [TBL] [Abstract][Full Text] [Related]
14. Characterization of phenotype-based pathogenic determinants of various Candida albicans strains in Jordan. Abu-Elteen KH; Elkarmi AZ; Hamad M Jpn J Infect Dis; 2001 Dec; 54(6):229-36. PubMed ID: 11862005 [TBL] [Abstract][Full Text] [Related]
15. Effect of Micafungin (FK463) on Candida albicans adherence to epithelial cells. Borg-von Zepelin M; Zaschke K; Gross U; Monod M; Müller FM Chemotherapy; 2002 Jul; 48(3):148-53. PubMed ID: 12138332 [TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitors may reduce pathogenicity and virulence in Candida albicans. Simonetti G; Passariello C; Rotili D; Mai A; Garaci E; Palamara AT FEMS Yeast Res; 2007 Dec; 7(8):1371-80. PubMed ID: 17627775 [TBL] [Abstract][Full Text] [Related]
17. Caspofungin-induced in-vitro post-antifungal effect and its impact on adhesion related traits of oral Candida dubliniensis and Candida albicans isolates. Ellepola AN; Chandy R; Khan ZU; Samaranayake LP Microbiol Immunol; 2016 Mar; 60(3):160-7. PubMed ID: 26850765 [TBL] [Abstract][Full Text] [Related]
18. Detection of human P-glycoprotein-like molecule in azole-resistant Candida albicans from HIV+ patients. Stringaro A; Molinari A; Calcabrini A; Arancia G; Ceddia PG; Cianfriglia M; Poloni F; Mondello F; Angiolella L; De Bernardis F; Cassone A Microb Drug Resist; 2002; 8(3):235-44. PubMed ID: 12363014 [TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso). Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462 [TBL] [Abstract][Full Text] [Related]
20. The influence of some antifungal drugs on in vitro adherence of Candida albicans to human buccal epithelial cells. Macura AB Mycoses; 1988 Jul; 31(7):371-6. PubMed ID: 3050514 [No Abstract] [Full Text] [Related] [Next] [New Search]